Novo Nordisk
-
Business
U.S. Obesity Rate Drops as GLP-1 Drug Prices Plunge
Roughly 11% of American adults now take a GLP-1 receptor agonist for weight management, a tenfold surge in usage since…
Read More » -
Business
Semaglutide Linked to Lower Alzheimer’s Risk in Diabetics
A massive analysis of electronic health records suggests that semaglutide, the active ingredient in Ozempic and Wegovy, is associated with…
Read More » -
Business
Cellular Intelligence Puts AI World Models Behind a Parkinson’s Therapy
BOSTON — Cellular Intelligence is applying artificial intelligence world models directly to clinical cell therapy, using predictive machine-learning architectures in…
Read More »
